Related Experiment Video

Updated: Jul 14, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Impact of obesity and bariatric surgery on cardiovascular disease

Michael A Mathier1, Ramesh C Ramanathan

  • 1UPMC Health System/Cardiovascular Institute, University of Pittsburgh School of Medicine, 200 Lothrop Street, S 559 Scaife Hall, Pittsburgh, PA 15213, USA.

The Medical Clinics of North America
|May 19, 2007
PubMed

Insights

Morbid obesity poses significant cardiovascular risks. Bariatric surgery offers a safe treatment, improving heart health by reducing obesity and associated cardiovascular issues.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Surgical Innovation

Background:

  • Morbid obesity is a major public health issue linked to numerous cardiovascular comorbidities.
  • Cardiovascular disease risk is elevated in individuals with morbid obesity.
  • Adipocyte-derived cytokines' role in obesity-related cardiovascular pathophysiology is an area of active research.

Purpose of the Study:

  • To evaluate bariatric surgery as a treatment for morbid obesity and its cardiovascular implications.
  • To assess the impact of surgically induced weight loss on cardiovascular health.
  • To investigate the modulation of adipocyte-derived cytokines after bariatric surgery.

Main Methods:

  • Review of existing literature on bariatric surgery outcomes in morbidly obese patients.
  • Analysis of cardiovascular risk factors, cardiac structure, and function pre- and post-surgery.
  • Exploration of studies examining adipokine levels and their correlation with cardiovascular changes.

Main Results:

  • Bariatric surgery demonstrates safety and efficacy in treating morbid obesity.
  • Significant improvements observed in cardiovascular risk factors post-surgery.
  • Positive effects on cardiac structure, function, and clinical outcomes in patients with cardiovascular disease.

Conclusions:

  • Bariatric surgery is a viable therapeutic option for managing morbid obesity and its cardiovascular complications.
  • Weight loss achieved through bariatric surgery effectively mitigates cardiovascular risks.
  • Further research is warranted to fully elucidate the role of adipokines in surgical weight loss and cardiovascular health.

More Related Videos

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

A Murine Model of Vertical Sleeve Gastrectomy06:47

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...